In another study conducted by Nazemian et al. [30], intraarticular injection of MSC-CM was able to decrease edema, hyperalgesia, serum TNF-α levels and intracellular signaling pathway factors activity alleviating inflammatory reactions of acute and chronic phases of CFA-induced arthritis. Here, TNF is linked to arthritic joint disease.